These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22930424)

  • 21. Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids.
    Elkhabaz A; Moseson DE; Brouwers J; Augustijns P; Taylor LS
    Mol Pharm; 2019 Dec; 16(12):5042-5053. PubMed ID: 31638397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media.
    Matteucci ME; Brettmann BK; Rogers TL; Elder EJ; Williams RO; Johnston KP
    Mol Pharm; 2007; 4(5):782-93. PubMed ID: 17715989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
    Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
    Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    J Pharm Sci; 2010 Mar; 99(3):1254-64. PubMed ID: 19697391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase Behavior and Crystallization Kinetics of a Poorly Water-Soluble Weakly Basic Drug as a Function of Supersaturation and Media Composition.
    Van Duong T; Ni Z; Taylor LS
    Mol Pharm; 2022 Apr; 19(4):1146-1159. PubMed ID: 35319221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
    Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.
    Matteucci ME; Miller MA; Williams RO; Johnston KP
    J Phys Chem B; 2008 Dec; 112(51):16675-81. PubMed ID: 19367943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.
    Patel DD; Joguparthi V; Wang Z; Anderson BD
    J Pharm Sci; 2011 Jul; 100(7):2623-41. PubMed ID: 21259238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug.
    Inoue K; Sugibayashi K
    Eur J Pharm Sci; 2012 Aug; 47(1):228-34. PubMed ID: 22728431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
    Anby MU; Williams HD; McIntosh M; Benameur H; Edwards GA; Pouton CW; Porter CJ
    Mol Pharm; 2012 Jul; 9(7):2063-79. PubMed ID: 22656917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Measurement of Amorphous Solubility.
    Štukelj J; Svanbäck S; Agopov M; Löbmann K; Strachan CJ; Rades T; Yliruusi J
    Anal Chem; 2019 Jun; 91(11):7411-7417. PubMed ID: 31050887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
    Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
    Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amorphous Solubility Advantage: Theoretical Considerations, Experimental Methods, and Contemporary Relevance.
    Ueda K; Moseson DE; Taylor LS
    J Pharm Sci; 2024 Sep; ():. PubMed ID: 39222748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of hydrate forms of paroxetine HCl from the amorphous state: an evaluation of thermodynamic and experimental predictive approaches.
    Pina MF; Pinto JF; Sousa JJ; Craig DQ; Zhao M
    Int J Pharm; 2015 Mar; 481(1-2):114-24. PubMed ID: 25592956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Polymers on the Supersaturation Potential of Poor and Good Glass Formers.
    Blaabjerg LI; Grohganz H; Lindenberg E; Löbmann K; Müllertz A; Rades T
    Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30241425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
    Brough C; Williams RO
    Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.